When was ELEM Biotech founded?

ELEM Biotech was founded in 2018 and raised its 1st funding round 2 years after it was founded.

Where is ELEM Biotech located?

ELEM Biotech is headquartered in Barcelona, Spain.

Who is the current CEO of ELEM Biotech?

Christopher Morton of ELEM Biotech. They have also founded 1 company.

How many employees does ELEM Biotech have?

As of Sep 30, 2026, the latest employee count at ELEM Biotech is 37.

Is ELEM Biotech a funded company?

ELEM Biotech is a funded company, having raised a total of $2.27M across 3 funding rounds to date. The company's 1st funding round was a $***** Grant (prize money) round, raised on Oct 01, 2020.

When was the latest funding round of ELEM Biotech?

ELEM Biotech's latest funding was a $***** Grant (prize money) round on 2023, with participation from 1 investor.

Where does ELEM Biotech rank among its competitors?

ELEM Biotech ranks 5th amongst 44 active competitors, of which 15 are funded. It stands 8th in terms of total funding among its competitors. The most recent competitor to raise funding was Virtonomy, which secured $5.88M in Dec, 2025.

Who are the top competitors of ELEM Biotech?

ELEM Biotech's top competitors include Unlearn, Ryght and Virtonomy. Among them, Virtonomy secured the most recent funding round in December, 2025.

ELEM Biotech - 2026 Company Profile, Team, Funding & Competitors

Company Details

Provider of a simulation based platform for doctors. It provides virtual clinical trials for cardiac resynchronization, cardiac cardiotoxicity, pain killer pumps, cardiac valve implants, flow rates, and concentrations for inhalers, drug delivery. It also provides a virtual cardiovascular system that incorporates the three fundamental physics electrical activity, mechanical deformation, and fluid mechanics. The respiratory system simulates definition fluid mechanics.

Website: www.elem.bio
Social
Email ID: *****@elem.bio
Phone Number: +34 **********

Key Metrics

Founded Year

2018

Location

Barcelona, Spain

Stage

Seed

Total Funding

$2.27M in 3 rounds

Latest Funding Round

Grant (prize money), 2023, $*****

Investors

EIC Fund & 2 more

Ranked

5^th among 44 active competitors

Employee Count

37 as on Sep 30, 2026

Similar Companies

Unlearn & 29 more

View ELEM Biotech's full profile

ELEM Biotech has raised a total funding of $2.27M over 3 rounds. Its first funding round was on Oct 01, 2020. Its latest funding round was a Grant (prize money) round on 2023 for $*****. 1 investor participated in its latest round. ELEM Biotech has 3 institutional investors.

Here is the list of recent funding rounds of ELEM Biotech:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
2023	6385	Grant (prize money)	4918	1025	3842	3359
Dec 24, 2021	8026095	Seed	3850506	1930933	3171982	1139444
Oct 01, 2020	1419960	Grant (prize money)	3576354	9380468	4110489	Europa

Access funding benchmarks and valuations. Sign up today!

View details of ELEM Biotech's funding rounds and investors

The founders of ELEM Biotech are Guillaume Houzeaux, Jose Maria Cela, Christopher Morton and Mariano Vazquez. Christopher Morton is the CEO of ELEM Biotech.

Here are the details of ELEM Biotech's key team members:

Guillaume Houzeaux: Co-Founder of ELEM Biotech. They are also an angel investor in 1 startup.
Contact Info: 1 email address
Jose Maria Cela: Co-Founder of ELEM Biotech.
Christopher Morton: Co-Founder & CEO of ELEM Biotech.
Mariano Vazquez: Co-Founder & CTO of ELEM Biotech.

View details of ELEM Biotech's Founder profiles and Board Members

ELEM Biotech's employee count trend

ELEM Biotech has 37 employees as of Sep 26. Here is ELEM Biotech's employee count trend over the years:

Uncover ELEM Biotech's growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of ELEM Biotech include Unlearn, Ryght and Virtonomy. Here is the list of Top 10 competitors of ELEM Biotech, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Unlearn 2017, San Francisco (United States), Series C	Developer of an AI platform for clinical trial design and analysis	$135M	EPIC Ventures, Altimeter Capital & 14 others	63/100
2nd	Ryght 2023, Anaheim (United States), Series A	Generative AI platform focused on biopharma smart biomedical data	$7.25M	Foothill Ventures, Virtue & 4 others	54/100
3rd	Virtonomy 2019, Munich (Germany), Series A	Provider of virtual patient simulation for medical device development	$9.69M	Dieter von Holtzbrinck Ventures, Companisto ... & 12 others	53/100
4th	Ebenbuild 2018, Munich (Germany), Seed	Provider of digital twin-based precision therapy solution	$2.78M	Bayern Kapital, HTGF & 2 others	39/100
5th	ELEM Biotech 2018, Barcelona (Spain), Seed	Provider of a simulation based platform for doctors	$2.27M	EIC Fund, GENESIS Biomed & 1 others	47/100
6th	Adsilico 2022, London (United Kingdom), Seed	Provider of insilico trials using virtual patients to assess medical device safety	$4.56M	Northern Gritstone, Parkwalk & 3 others	38/100
7th	Verto Health 2017, Toronto (Canada), Seed	Provider of AI-based digital twin platform for population health management	$1.52M	MaRS IAF, Graphite Ventures & 5 others	37/100
8th	Precision Diagnosis Technology Series B	Provider of digital twin technology for precision medicine	$15.5M	Zhiyou Scientist Fund, Qirong Venture Capital	34/100
9th	XY.ai 2017, Palo Alto (United States), Unfunded	Provides software for managing genetic and health data	-	-	33/100
10th	Akkure 2016, Dublin (Ireland), Seed	Provider of a blockchain technology based online platform for genomic data analytics	$3.37M	Enterprise Ireland, Digital Transformation Innovation Fund ... Read more	32/100